Form D · Other Health Care
Sparta Biomedical Inc.
Madison, NJ · CIK 0001901419
Offering snapshot reported Jan 7, 2022 · SEC filing
- Reported sold
- $5.28M Offering amount: $5.43M
- Investors reported
- 53 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 7, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 7, 2022 | Initial | $5,282,391 | No comparison | 53 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-428314
Source: Form D, filed Jan 7, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dimitrios Angelis | Director, Executive |
| Sean Fontenot | Director |
| Ken Gall | Director |
| Dushyanth Surakanti | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
300 Main Street #202
Madison, NJ, 07940
Madison, NJ, 07940